no code implementations • 18 Jul 2022 • Xiao Gan, Zixin Shu, Xinyan Wang, Dengying Yan, Jun Li, Shany ofaim, Réka Albert, XiaoDong Li, Baoyan Liu, Xuezhong Zhou, Albert-László Barabási
We validate our framework with real-world hospital patient data by showing that (1) shorter network distance between symptoms of inpatients correlates with higher relative risk (co-occurrence), and (2) herb-symptom network proximity is indicative of patients' symptom recovery rate after herbal treatment.
2 code implementations • 15 Apr 2020 • Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, Susan Dina Ghiassian, JJ Patten, Robert Davey, Joseph Loscalzo, Albert-László Barabási
The current pandemic has highlighted the need for methodologies that can quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections.